Loading clinical trials...
Loading clinical trials...
Evaluation of Efficacy and Safety of Autologous MSCs Combined to Biomaterials to Enhance Bone Healing in Patients With Delayed Consolidation After Long Bone Fracture Requiring Graft Apposition or Alternative Orthobiologics
Conditions
Interventions
Implantation of bone substitute plus autologous cultured mesenchymal cells
Locations
5
France
Depatment of Orthopaedic Surgery, Hôpital Henri Mondor
Créteil, France
Department of Orthopaedic Surgery, CHRU Tours
Tours, France
Department of Orthopaedic Trauma, University of Ulm
Ulm, Germany
Istituto Ortopedico Rizzoli, Bologna
Bologna, Italy
Servicio de Cirugía Ortopédica y Traumatología "A", Hospital La Paz
Madrid, Spain
Start Date
May 1, 2013
Primary Completion Date
February 5, 2016
Completion Date
February 5, 2016
Last Updated
January 30, 2025
Lead Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions